← Insider buys
MRNA

Moderna, Inc. · Healthcare

Director Noubar Afeyan sold $760K of Moderna, Inc.

Sold$760,032
$76.00Price
10,000Shares

What MRNA did after the filing

Filed Nov 3Copier in Nov 6
The stock from Mon, Nov 6 open, $78.04
+14.2%
S&P 500, same days
+9.5%

Measured over 30 trading days, to the Dec 19 close.

Traded Wed, Nov 1. Filed Fri, Nov 3, 7:00 PM ET, after the close. Returns use the Nov 6 open and the Dec 19 close. Not investment advice.